AtriCure, Inc. (ATRC)
56.84
+0.86
(+1.54%)
USD |
NASDAQ |
Nov 13, 16:00
56.84
0.00 (0.00%)
After-Hours: 19:59
AtriCure EPS Diluted (Quarterly) : 0.0816 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0816 |
| June 30, 2026 | 0.1832 |
| March 31, 2026 | 0.0022 |
| December 31, 2025 | 0.0366 |
| September 30, 2025 | -0.0056 |
| June 30, 2025 | -0.1297 |
| March 31, 2025 | -0.1424 |
| December 31, 2024 | -0.3304 |
| September 30, 2024 | -0.1667 |
| June 30, 2024 | -0.1707 |
| March 31, 2024 | -0.284 |
| December 31, 2023 | -0.2108 |
| September 30, 2023 | -0.1951 |
| June 30, 2023 | -0.1106 |
| March 31, 2023 | -0.1405 |
| December 31, 2022 | -0.0908 |
| September 30, 2022 | -0.2678 |
| June 30, 2022 | -0.3248 |
| March 31, 2022 | -0.3335 |
| December 31, 2021 | -0.3031 |
| September 30, 2021 | 2.106 |
| June 30, 2021 | -0.3608 |
| March 31, 2021 | -0.379 |
| December 31, 2020 | -0.4207 |
| September 30, 2020 | -0.1124 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1978 |
| March 31, 2020 | -0.4243 |
| December 31, 2019 | -0.4215 |
| September 30, 2019 | -0.2474 |
| June 30, 2019 | -0.1098 |
| March 31, 2019 | -0.1524 |
| December 31, 2018 | -0.094 |
| September 30, 2018 | -0.2153 |
| June 30, 2018 | -0.0102 |
| March 31, 2018 | -0.3078 |
| December 31, 2017 | -0.08 |
| September 30, 2017 | -0.22 |
| June 30, 2017 | -0.21 |
| March 31, 2017 | -0.32 |
| December 31, 2016 | -0.27 |
| September 30, 2016 | -0.21 |
| June 30, 2016 | -0.26 |
| March 31, 2016 | -0.31 |
| December 31, 2015 | -0.36 |
| September 30, 2015 | -0.22 |
| June 30, 2015 | -0.18 |
| March 31, 2015 | -0.19 |
| December 31, 2014 | -0.20 |
| September 30, 2014 | -0.02 |
| June 30, 2014 | -0.10 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5294 |
| Boston Scientific Corp. | 0.4008 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.0348 |
| Baxter International, Inc. | 0.5654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.064M |
| Revenue (Quarterly) | 154.45M |
| Total Expenses (Quarterly) | 150.39M |
| Enterprise Value | 2.760B |
| Gross Profit Margin (Quarterly) | 76.80% |
| Profit Margin (Quarterly) | 2.63% |
| Earnings Yield | 0.53% |
| Operating Earnings Yield | 0.65% |
| Normalized Earnings Yield | 0.5598 |